Published in Cancer Weekly, November 28th, 2006
A study led by Rush, which also included Tufts-New England Medical Center, and Rhode Island Hospital/Brown Medical School, found the Perspecta has significant potential to achieve better quality in radiation treatment planning. The study results were presented at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.